Search results - ORA - Oxford University Research Archive

1 - 3 of 3

1

Conference item

MEDI 167-Discovery of the highly potent, selective and orally bioavailable CCR9 antagonist CCX282-B

Ungashe, S, Wei, Z, Rubas, W, et al.
2008-04-06

2

Journal article

Characterization of CCX282-B, an orally bioavailable antagonist of the CCR9 chemokine receptor, for treatment of inflammatory bowel disease.

Walters, M, Wang, Y, Lai, N, et al.
2010-10-01

3

Journal article

Pharmacological inhibition of CCR9 is a novel approach in the treatment of inflammatory bowel disease

Bekker, P, Keshav, S, Wei, Z, et al.
2007-06-01

TO TOP